Vis enkel innførsel

dc.contributor.authorGidske, Gro
dc.contributor.authorSandberg, Sverre
dc.contributor.authorFauskanger, Pernille Kjeilen
dc.contributor.authorPelanti, Jonna
dc.contributor.authorTollånes, Mette Christophersen
dc.contributor.authorSolsvik, Anne Elisabeth
dc.contributor.authorSølvik, Una Ørvim
dc.contributor.authorVie, Wenche Sletbakk
dc.contributor.authorStavelin, Anne
dc.date.accessioned2023-10-20T11:29:40Z
dc.date.available2023-10-20T11:29:40Z
dc.date.created2023-09-25T19:01:25Z
dc.date.issued2023
dc.identifier.issn1434-6621
dc.identifier.urihttps://hdl.handle.net/11250/3097783
dc.description.abstractObjectives We report the results of glucose measurements performed during one year by the same measurement procedures (MPs) in 58 Norwegian hospital laboratories using control materials provided by external quality assessment (EQA) schemes from two different providers. The providers used materials with presumed vs. verified commutability and transfers of values using reference material vs. using a highest-order reference MP. Methods Data from six Labquality and three Noklus glucose EQA surveys were aggregated for each MP (Abbott Alinity, Abbott Architect, Roche Cobas, and Siemens Advia) in each scheme. For each EQA result, percent difference from target value (% bias) was calculated. Median percent bias for each MP per scheme was then calculated. Results The median % biases observed for each MP in the Labquality scheme were significantly larger than those in the Noklus scheme, which uses verified commutable control materials and highest-order reference MP target values. The difference ranged from 1.2 (Roche Cobas, 2.9 vs. 1.7 %) to 4.4 percentage points (Siemens Advia, 3.2 % vs. −1.2 %). The order of bias size for the various MPs was different in the two schemes. In contrast to the Labquality scheme, the median % biases observed in the Noklus scheme for Abbott Alinity (−0.1 %), Abbott Architect (−0.5 %), and Siemens Advia (−1.2 %) were not significantly different from target value (p>0.756). Conclusions This study underlines the importance of using verified commutable EQA materials and target values traceable to reference MPs in EQA schemes designed for assessment of metrological traceability of laboratory results.en_US
dc.language.isoengen_US
dc.publisherDe Gruyteren_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleAggregated data from the same laboratories participating in two glucose external quality assessment schemes show that commutability and transfers of values to control materials are decisive for the biases founden_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1515/cclm-2023-0532
dc.identifier.cristin2178743
dc.source.journalClinical Chemistry and Laboratory Medicineen_US
dc.identifier.citationClinical Chemistry and Laboratory Medicine. 2023.en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal